Compare iShares Core Growth Allocation ETF (AOR) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core Growth Allocation ETF vs BioNTech SE - ADR — how do they compare? iShares Core Growth Allocation ETF trades at $69.87, while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: iShares Core Growth Allocation ETF is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| AOR | BNTX | |
|---|---|---|
52-Week High | $70.12 | $119.34 |
52-Week Low | $62.26 | $83.89 |
Market Cap | — | $23.31B |
Sector | — | Health |
Enterprise Value | — | $6.60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Core Growth Allocation ETF
The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model.
Read more on AOR →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
